Purpose: Nuclear cardiology plays an important role in clinical assessment and has enormous impact on the management of a variety of cardiovascular diseases. Pediatric patients at different age groups are exposed to a spectrum of radiation dose levels and associated cancer risks different from those of adults in diagnostic nuclear medicine procedures. Therefore, comprehensive radiation dosimetry evaluations for commonly used myocardial perfusion imaging (MPI) and viability radiotracers in target population (children and adults) at different age groups are highly desired. Methods: Using Monte Carlo calculations and biological effects of ionizing radiation VII model, we calculate the S-values for a number of radionuclides and estimate the absorbed dose and effective dose for 12 MPI radiotracers in computational models including the newborn, 1-, 5-, 10-, 15-yr-old, and adult male and female computational phantoms. Tc-labeled tracers. However, this advantage is less apparent in children. The produced dosimetric databases for various radiotracers used in cardiovascular imaging, using new generation of computational models, can be used for risk-benefit assessment of a spectrum of patient population in clinical nuclear cardiology practice. C 2015 American Association of Physicists in Medicine. [http://dx
INTRODUCTION
Nuclear cardiovascular imaging plays a pivotal role in the assessment of myocardial ischemia, infarction, and damage associated with various congenital or acquired heart diseases. 1 Each year, more than 10 × 10 6 nuclear cardiac studies are performed in the US for the assessment of myocardial perfusion and/or viability. 2 These procedures are performed using a variety of either single-photon-emitting (SPECT) or positron-emitting (PET) radiotracers, involving the exposure of patients to radiation ranging between 5 and 57 mSv. 2 The growth of nuclear cardiology studies led to substantial increase of radiation dose to patients, placing them as major contributors to global radiological burden, actually accounting for 85% of nuclear medicine exposure to the US population. 3 In pediatric cardiology, myocardial perfusion imaging (MPI) is used in cardiac stress tests of children, 4 monitoring of myocardial ischemia, 5 evaluation of the effects of coronary arterial intervention, 6 stratification of cardiac risks of children with Kawasaki disease, 7 detection of congenital heart disease, 8 identification of myocardial perfusion in children after arterial switch operation, 9 estimation of right ventricular pressure overload, 10 and determination of myocardial disease (such as hypertrophic cardiomyopathy and cardiomyopathy in Duchenne muscular dystrophy). 11 However, the exposure of pediatric patients to ionizing radiation during nuclear cardiology procedures is a matter of concern. 12, 13 With the same absolute level of radiation dose, children may experience greater stochastic effects from ionizing radiation than adults because they have a proportionally higher percentage of T I. Organ masses of computational phantoms. replicating cells, which are more radiosensitive than other cells.
14 Since children have longer postirradiation life period for the emergence of deleterious stochastic effects, they are also at higher cancer risk from ionizing radiation compared to adults. 15 Therefore, the assessment of absorbed radiation dose for patient populations of various age groups resulting from nuclear cardiology imaging procedures (SPECT and PET) is of paramount importance in clinical practice.
To this end, organ absorbed doses are often estimated using computational phantoms and Monte Carlo calculations. [16] [17] [18] [19] [20] [21] [22] These phantoms and computer codes, respectively, mimic the morphology and internal anatomic structures of the human body and simulate the interaction of ionizing radiation with biological tissues, thus allowing tracking the transport of radiation in the body. Depending on their geometric features, computational models can be divided into three basic categories: stylized models which employ simple equationbased mathematical functions, voxel-based models which use matrices obtained from segmented medical images, and boundary representation (BREP) models which employ nonuniform rational B-splines (NURBS) or polygonal meshes to represent the surface contour of individual organs and the whole body. [23] [24] [25] [26] In most studies reported in the literature, the estimation of organ absorbed dose for a spectrum of populations of different ages from radiopharmaceuticals used in nuclear cardiology was performed using mathematical phantoms, [27] [28] [29] voxel-based models of the same subject.
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For a variety of exposure conditions, the differences of effective dose between stylized adult phantom and voxel-based adult phantom of ICRP reference anatomic data have been reported to range between −50% and 60%. 40 For pediatric populations, the relative differences of the effective dose between University of Florida-National Cancer Institute (UF-NCI) phantoms and stylized phantoms may change between −24% and 33% for positron-emitting radiotracers. 35 Therefore, the assessment of organ absorbed dose and effective dose for commonly used nuclear cardiology radiotracers using new generation computational phantoms is desired.
In this work, we use the UF-NCI family of pediatric models and the ICRP reference adult voxel-based phantom to perform Monte Carlo-based particle transport simulation of radiation emitted by different radionuclides (Tl-201, Tc-99m, I-123, C-11, N-13, O-15, F-18, and Rb-82) to calculate S-values for the considered series of anatomical models. The obtained radiation dosimetry database is then used for the assessment of organ absorbed doses and effective dose of 12 radiotracers used in nuclear cardiac imaging. The effective dose per unit administered activity of 12 radiotracers was calculated for the newborn, 1-, 5-, 10-, 15-yr-old, and adult population based on the new ICRP tissue-weighting factors. Understanding the variability of the absorbed dose with patient's body weight and age may advance the perception of the uncertainties involved in internal radiation dosimetry calculations and risk-benefit analyses in pediatric nuclear cardiology practice. The detailed age-specific dosimetric calculations can be used for both prospective monitoring of cumulative exposure to chronic patients requiring multiple diagnostic procedures, as well as retrospective epidemiological studies.
MATERIALS AND METHODS

2.A. Computational phantoms
The UF-NCI hybrid pediatric phantom series were developed from patients' CT images using 3D image segmentation software and Rhinoceros package. The modeled NURBSbased UF-NCI phantoms were voxelized using an in-house  code. For the alimentary tract organs of the UF-NIC phantoms, the central trace of each segment was first extracted from original patient CT images and adjusted to match corresponding ICRP reference lengths. A NURBS pipe model was then generated along the constructed central tracks until a realistic shape and curvature were obtained. The thicknesses of the alimentary tract wall were modified to match corresponding ICRP reference masses. The voxelized UF-NCI computational phantom series, including the reference newborn, 1-, 5-, 10-, and 15-yr-old male and female models, and the ICRP reference adult male and female phantoms, were used in this work to represent patient populations of various ages for Monte Carlo-based internal radiation dosimetry calculations. The organ masses and body weights of the UF-NCI phantoms and ICRP reference models are close to the recommended anatomical data reported by the ICRP for population of corresponding age groups. 41, 42 A unified voxel dimension of 1.8×1.8×3 mm 3 was set for all computational models (interpolated from the original resolution) to minimize the differences across different models. For the sake of convenience in terms of effective dose calculation, homogeneous organs such as the left lung and right lung, the submaxillary salivary gland and sublingual salivary gland, the cartilage, cortical bone, and spongiosa at different bone sites were merged as one identified region. A unified organ ID was set for the UF-NCI phantom series and ICRP models. Body weights and organ/tissue masses for the pediatric and adult phantoms are summarized in Table I . Figure 1 shows the front 3D views of the 12 computational phantoms used in this work.
2.B. Monte Carlo simulations
The Monte Carlo N-particle extended-X-code (version 2.5.c) was adopted for radiation transport simulation in the UF-NCI and ICRP reference phantoms. The decay data of the investigated radionuclides were obtained from the radiation dose assessment resource (RADAR).
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Uniformly distributed radionuclide sources (Tl-201, Tc-99m, I-123, C-11, N-13, O-15, F-18 , and Rb-82) were simulated in 48 source regions. The energy spectrum of photons, positrons, and electrons were determined from the decay schemes of the investigated isotopes and were manually defined in X input file. See supplementary Table A15 for decay data of the investigated radionuclides. 61 The energy deposition in the target regions was recorded in unit of MeV per particle using the X tally card * F8. The MCPLIB02 photon cross section library and the default electron/positron transport algorithms of  were adopted for radiation transport simulations. An in-house ++ code was developed to process the output of the  code and calculate the S-values of radionuclides as well as the absorbed doses and effective doses for the considered radiotracers using published biokinetic data from various sources 28, 29, 44, 45 and the tissue weight factors recommended by ICRP publication 103. 46 The density and elemental compositions of organs/tissues for each anatomical model were obtained from the reference data reported in ICRP publication 89. 42 A total of 1.0 × 10 7 primary particles were generated such that the statistical uncertainty in terms of coefficient of variation was less than 2% in most cases.
2.C. Cardiovascular imaging radiotracers
The radiotracers investigated in this work are Tl has been extensively used as a perfusion radiotracer in cardiovascular imaging owing to its excellent myocardial first pass extraction and good relationship between blood flow and myocardial uptake at higher flow rates during stress testing. I-BMIPP proved to be a useful iodinated branch chain fatty acid for evaluation of myocardial fatty acid uptake. 50 , 51 11 C-labeled radiotracers, such as 11 C-meta-hydroxyephedrine, are adopted for PET imaging of heart failure. 52 13 N-ammonia, 15 O-water, 82 Rb, and 18 F-FDG are common PET tracers and are increasingly used for myocardial perfusion and viability studies because of advantages they offer in terms of improved diagnostic accuracy and functional assessments. 53 18 F-LMI1195 is a novel of 12 nuclear cardiology radiotracers were calculated for the newborn, 1-, 5-, 10-, 15-yr-old, and the adult male and female computational phantoms according to the medical internal radiation dose (MIRD) schema. 56 The radiation absorbed dose D(r T ,T D ) delivered to any target tissue r T from source organ r S is given by
whereÃ(r S ,T D ) is the cumulated (time-integrated) activity of the radiopharmaceutical in the source region and S(r T ← r S ) is the S-value describing the equivalent dose rate in the target organ per unit activity in the source organ. The latter can be calculated by
, where E i is the individual energy of the ith radiation, Y i is the yield of ith radiation per nuclear transformation, M T is the mass of the target organ, φ(r T ← r S ,E i ) is the absorbed fraction given by φ(r T ← r S ,E i ) = E d /E i , where E d is the recorded energy deposition in the target tissue. The uncertainty estimation of S-values for isotope R in target organ r T is given by
where F i and x i are output relative errors and scored values by  tallies for the ith radiation in the considered target regions, respectively.
The equivalent dose, which relates the absorbed dose to stochastic effects, is calculated by multiplying the absorbed dose of organs by the radiation-weighting factors. To reflect the combined detriment from stochastic effects of equivalent doses in all organs of the human body, the concept of effective dose was introduced by the ICRP and is calculated by the sum of the product of tissue-weighting factor (ω T ) and equivalent doses. 46 The effective dose is defined by a weighted sum of tissue equivalent doses as Effective dose
, where ω T is the tissue-weighting factors for target organ r T , ω R is the radiation-weighting factor for radiation type R, and H r T is the absorbed equivalent dose in the target organ from the administered radiotracer.
RESULTS
3.A. S-values
The S-values of eight investigated radionuclides for the considered source-target organ pairs were calculated in the considered computational phantoms. and this work may be attributed to the differences between the geometries of the stylized and voxelbased models. Figure 3 shows the self-absorbed S-values of Tl-201 and Tc-99m for selected internal organs. For all radionuclides, the self-absorbed S-values of organs decrease when the body weight increases and present with negative correlations with organ mass. The correlation between the cross-absorbed Svalues and body weight is more complicated because the energy deposition pattern of particles in the target region from cross-irradiation is more affected by source/target distance.
Figures 4 and 5 illustrate the self-absorbed S-values for the stomach wall and colon wall and the cross-absorbed Svalues for the liver irradiating the kidney and the kidney irradiating the adrenals, respectively, for the defined computational phantoms and the eight considered radionuclides. Of these radionuclides, Rb-82 and Tc-99m produce the largest and lowest self-absorbed S-values for most organs, respectively. For SPECT radionuclides, the self-absorbed organ S-values for Tl-201 and I-123 are quite similar and about 70%-190% larger than those obtained for Tc-99m, while the cross-absorbed organ S-values for Tl-201 and Tc99m are comparable and about 50%-60% smaller than those obtained for I-123. The cross-absorbed S-values of C-11, N-13, O-15, and F-18 are similar and about 9 times higher than those of Tl-201 and Tc-99m. A plausible explanation of these observations is that the cross-absorbed S-values are mostly contributed by photons 38 and the 511 keV annihilation photons emitted by positron-emitting radionuclides contribute similar energy deposition patterns and result in higher energy deposition in target regions than the low-energy photons emitted by Tl-201 and Tc-99m.
3.B. Absorbed dose and effective dose
The absorbed dose to 48 target organs from the 12 investigated radiotracers was calculated in the considered computational phantoms. It was observed that the highest absorbed dose to critical organs is delivered to the testes, kidney, thyroid, and heart wall for 201 Tl; gall bladder wall, kidney, salivary glands, liver, uterus, colon wall, and urinary bladder wall for Tc-furifosmin; heart wall, liver, and urinary bladder wall for 123 I-BMIPP; the UB wall and uterus for 11 C (realistic maximum model); the liver, urinary bladder wall, and kidney for 13 N-ammonia; the liver, spleen, thyroid, and testes for 15 O-water; the kidney, heart wall, and liver for 18 F-flurpiridaz; the heart wall and urinary bladder wall for 18 F-FDG; the urinary bladder wall and thyroid for 18 F-LMI1195; and uterus, kidney, and lung for 82 Rb. Figure 6 shows the absorbed dose from considered radiotracers for the heart wall, UB wall, kidney, and liver for the newborn, 1-, 5-, 10-, 15-yr-old female, and the adult male and female models. For the kidney, the absorbed dose from 201 Tl is about 300, 90, and 20 times higher than from 15 O-water, 82 Rb, and 99m Tcsestamibi (rest), respectively. For most radiotracers, the organ absorbed dose per unit administered activity decreases when the body weight increases. Among all considered radiotracers, 201 Tl produces the highest absorbed dose to all organs because of the long half-life of the radionuclide (73 h), in contrast to the relatively shorter half-lives of 15 O-water and 82 Rb (2.04 and 1.27 min), respectively, which produces the lowest absorbed dose in most organs. However, for the UB wall, Rb. For most organs, organ absorbed doses in the newborn phantom are 3.6-8.5 times higher than those of 10-yr-old phantom and 7.6-13.1 times higher than those of the adult for the considered radiotracers.
The effective dose per unit administered activity of 12 radiotracers in the newborn, 1-, 5-, 10-, 15-yr-old, and adult models calculated using tissue-weighting factors of the ICRP 103 is shown in Fig. 8 46 which are not age-and gender-specific and were used in this work for the calculation of the effective dose of both adult and pediatric phantoms. For children at different ages, the use of the effective dose calculated from recommended tissueweighting factors may introduce uncertainties less than 40%. 59 Variability is also introduced when effective doses are calculated using different tissue-weighting factors. The mean relative difference between effective doses calculated using ICRP 60 and ICRP 103 tissue-weighting factors was reported to be about 7.3% ± 9.1% for positron-emitting radiotracers using pediatric models. 35 The dose estimation in diagnostic nuclear medicine is commonly based on mean or median biokinetic data of a small group of animal or human subjects and the involved uncertainties have been reported to be within the range of 10%-30% for computational models (organs/tissues) of different sizes. 60 The development of novel nuclear cardiology imaging probes for diagnosis of cardiovascular disease is an active research field. 53 Accurate dose calculations for representative patient groups at different ages are needed to optimize the dose regimens of various radiotracers and to investigate the collective radiation exposure and risks associated with nuclear medicine procedures. In this work, we estimated the S-values for Tl-201, Tc-99m, I-123, C-11, N-13, O-15, F-18, and Rb-82 using a new generation of age-and sex-dependent computational phantoms including the newborn, 1-, 5-, 10-, 15-yrold, and adult male and female and calculated organ absorbed doses and effective doses of 12 radiotracers used in nuclear cardiology based on the latest available dosimetric data.
The Monte Carlo method is a powerful and popular tool for internal radiation dosimetry calculation where accurate dose estimates are grounded on reliable computational phantoms that mimic the internal anatomic geometries and physical characteristics of the human body. The equivalent dose to patients from administered radiotracers is frequently calculated from tabulated absorbed dose rate derived from stylized phantoms. [27] [28] [29] [30] [31] However, significant differences between the dosimetric characteristics of stylized and voxel-based models for the same subject are often reported. [33] [34] [35] [36] [37] [38] Since some biological organs/tissues in populations of different ages may have substantially different physical and biochemical characteristics and present with different radiosensitivity and radiation risks, the evaluation of age-dependent absorbed dose using realistic anatomical computational phantoms is commended.
Among the evaluated radionuclides, Tl-201, Tc-99m, and I-123 are adopted for SPECT cardiovascular imaging while C-11, N-13, O-15, F-18, and Rb-82 are commonly used for PET cardiovascular imaging. The organ absorbed dose depends on the S-value and physical half-life of the radionuclide and the biological half-life and biodistribution of the radiotracer. For most organs, Rb-82 produces the highest self-absorbed S-values which decrease with increasing age and weight and the second lowest absorbed organ dose because of its short half-life. Overall, among the considered nuclear cardiology radiotracers, Tl-201-labeled tracers produce the highest absorbed dose and effective dose in humans; I-123 and F-18-labeled tracers produce the second highest radiation dose, while Tc-99m and C-11-labeled tracers produce the third highest radiation dose. A lower effective dose in adults is observed for 82 Rb-labeled tracers compared to 99m Tclabeled tracers, while this advantage is less apparent in children.
CONCLUSION
A systematic study was conducted to evaluate the radiation dose from nuclear cardiology (SPECT and PET) procedures to pediatric and adults populations using the latest generation computational phantoms and the up-to-date dosimetric data available. The generated database of organ absorbed dose and effective dose for radiotracers used in nuclear cardiovascular imaging can be used for radiation risk assessment for the pediatric and adult population in clinical routine.
